Mach; Francois

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mach; Francois.The latest application filed is for "compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the hdl cholesterol level".

Company Profile

0.5.16

Mach; Francois - Geneva CH
Mach; Francois - Geneve CH
Mach; Francois - Vesenaz CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the HDL cholesterol level Grant 11,266,680 - Salome , et al. March 8, 2	2022-03-08
Compositions Based On Methyl Cyclodextrins For The Treatment And/or Prevention Of Diseases By Increasing The Hdl Cholesterol Level App 20180207198 - Salome; Marc ; et al.	2018-07-26
Compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the HDL cholesterol level Grant 10,022,392 - Salome , et al. July 17, 2	2018-07-17
Anti-RANTES Antibodies App 20150079099 - Fischer; Nicolas ; et al.	2015-03-19
Anti-RANTES antibodies Grant 8,673,299 - Fischer , et al. March 18, 2	2014-03-18
Anti-RANTES Antibodies and Methods of Use Thereof App 20120201826 - Fischer; Nicolas ; et al.	2012-08-09
Anti-RANTES antibodies Grant 8,012,474 - Fischer , et al. September 6, 2	2011-09-06
Anti-RANTES antibodies and methods of use thereof App 20090148455 - Fischer; Nicolas ; et al.	2009-06-11
Cannabinoid Compositions and Methods of Use Thereof App 20080262079 - Mach; Bernard ; et al.	2008-10-23
Statins (HMG-COA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent App 20070003636 - Mach; Francois	2007-01-04
Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent App 20050187285 - Mach, Francois	2005-08-25
Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent App 20040102512 - Mach, Francois	2004-05-27
Methods for treatment of multiple sclerosis with statins App 20040013643 - Mach, Francois	2004-01-22
Treatment of rheumatoid arthritis with statins (HMG-CoA reductase inhibitors) App 20030065019 - Mach, Francois	2003-04-03
Treatment of diabetes with statins (HMG-COa reductase inhibitors) App 20030060502 - Mach, Francois	2003-03-27
Facilitating tissue grafts with statins (HMG-COa reductase inhibitors) App 20030060501 - Mach, Francois	2003-03-27
Facilitating organ transplantation with statins (HMG-CoA reductase inhibitors) App 20030060500 - Mach, Francois	2003-03-27
Treatment of multiple sclerosis with statins (HMG-CoA reductase inhibitors) App 20020159974 - Mach, Francois	2002-10-31
Treatment of psoriasis with statins (HMG-Coa reductase inhibitors) App 20020159973 - Mach, Francois	2002-10-31
Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent App 20020156122 - Mach, Francois	2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.